AGA’s Hepatitis B Virus Reactivation Guideline is Now Open for Public Comment

The American Gastroenterological Association (AGA) has announced that their latest guideline, the “AGA Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in Immunosuppressed Individuals” is now open for public comment. This guideline, aimed at educating and providing guidance to frontline health practitioners on the prevention and management of Hepatitis B virus reactivation (HBVr) in their clinical practice.

This document serves as an update to AGA’s first HBVr guideline published in 2014, located here. It has been revised to include the latest evidence and recommendations, as well as new classes of immunosuppressive therapies that have been developed and approved for use. The final version of this guideline is anticipated to be released in February 2025.

As part of AGA’s development process, they invite reviews and feedback from the public. Interested parties are encouraged to submit their comments here by September 25, 2024. Your input is valuable in shaping the future of hepatitis B reactivation prevention and management.